Hormone replacement therapy: controversies, pros and cons.

Area of Science:

• Reproductive Endocrinology
• Clinical Pharmacology
• Women's Health

Background:

• Hormone replacement therapy (HRT) encompasses estrogen-plus-progestin therapy (OPT) and estrogen-only therapy (OT).
• Extensive research exists for OPT, yet further investigation into OT is warranted.
• Assessing HRT's complex risk-benefit profile is crucial for clinical decision-making.

Purpose of the Study:

• To provide a comprehensive overview of the key risks and benefits associated with HRT.
• To aid clinicians and patients in navigating the complexities of HRT decisions.
• To synthesize current data on HRT, acknowledging conflicting findings.

Main Methods:

• Review and analysis of existing clinical trial data on HRT.
• Examination of discrepancies and consistencies across various HRT studies.
• Focus on primary risks (breast cancer, cardiovascular health) and major benefits (symptom relief, fracture reduction).

Main Results:

• HRT use is associated with a slight increase in breast cancer incidence compared to placebo.
• Cardiovascular risks include increased stroke and venous thromboembolism (VTE), alongside potential cardioprotective effects.
• Significant benefits include relief of menopausal symptoms and decreased fracture risk.

Conclusions:

• HRT presents a complex risk-benefit profile requiring careful individual assessment.
• Conflicting data necessitates critical analysis for informed clinical practice.
• Understanding both risks and benefits is essential for optimizing patient care in HRT management.